Effect of Nitrous Oxide on Intravenous Closed-loop Anesthesia (Drone-N2O)

September 23, 2016 updated by: Hopital Foch

Anesthésie Totale Intraveineuse en " Boucle d'Asservissement " guidée Par l'Index Bispectral : Effet de l'Adjonction de Protoxyde d'Azote (Effect of Nitrous Oxide on Intravenous Closed-loop Anesthesia)

The main objective of the study is to analyze the influence of nitrous oxide on propofol and remifentanil requirements.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Nitrous oxide is a widely used anesthetic agent. The mechanism of its central action is not completely understood and its importance is questioned.

Total intravenous anesthesia can be driven by a computer using bispectral index as a controller. Such a system matches anesthetic agent requirements to the needs of each individuum and thus allows an unbiased evaluation of the influence of nitrous oxide. Two groups of patients are compared: one ventilated with a oxygen-air mixture and one with oxygen-nitrous oxide mixture. Anesthesia is provided by a "dual-loop" which adapts propofol and remifentanil target concentrations to maintain a bispectral index between 40 and 60 in both groups.

Study Type

Interventional

Enrollment (Actual)

672

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brussels, Belgium
        • Hôpital Erasmes
      • Angers, France
        • CHU d'Angers
      • Argenteuil, France, 95100
        • CH Victor Dupouy
      • Besançon, France, 25030
        • CHU de Besancon
      • Bordeaux, France, 33000
        • Clinique Saint Augustin
      • Clichy, France, 92110
        • Hôpital Beaujon
      • Dreux, France, 28102
        • Centre Hospitalier de Dreux
      • Le Kremlin-Bicêtre, France, 94275
        • Hopital de Bicetre
      • Marseille, France, 13009
        • Institut Paoli-Calmettes
      • Nouméa, France, 98849
        • Centre Hospitalier Territorial Gaston Bourret
      • Paris, France, 75014
        • Hopital Cochin
      • Paris, France, 75013
        • Hôpital Pitié-Salpêtrière
      • Strasbourg, France, 67200
        • Hopital de Hautepierre
      • Suresnes, France, 92151
        • Hopital Foch
      • Toulouse, France, 31052
        • Institut Claudius Regaud
      • Tours, France, 37044
        • Hôpital Trousseau
      • Berlin, Germany, D - 10117
        • La Charite

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • General anaesthesia with controlled ventilation

Exclusion Criteria:

  • Age lower than 18 years
  • Pregnant woman
  • Allergy to the propofol or to a muscle myorelaxant
  • Patients receiving a psychotropic treatment
  • Presence of a central neurological disorder or a lesion cerebral
  • Patients having an anomaly of blood cells count preoperative biological assessment
  • Patients having had an anaesthesia in the previous month

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 1
ventilation with air and oxygen
60% air combined with 40% oxygen for ventilation
Experimental: 2
ventilation with nitrous oxide and oxygen
60% nitrous oxide combined with 40% oxygen for ventilation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Measure: influence of nitrous oxide on the automated administration of propofol and remifentanil.
Time Frame: during anesthesia
during anesthesia

Secondary Outcome Measures

Outcome Measure
Time Frame
Measure: consequences of the use of nitrous oxide on the performance of the automated administration system.
Time Frame: during anesthesia
during anesthesia
Influence of Gender
Time Frame: during anesthesia
during anesthesia

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Marc Fischler, MD, Hopital Foch, 92150 Suresnes, France

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2007

Primary Completion (Actual)

November 1, 2009

Study Completion (Actual)

November 1, 2009

Study Registration Dates

First Submitted

October 19, 2007

First Submitted That Met QC Criteria

October 19, 2007

First Posted (Estimate)

October 22, 2007

Study Record Updates

Last Update Posted (Estimate)

September 26, 2016

Last Update Submitted That Met QC Criteria

September 23, 2016

Last Verified

September 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia

Clinical Trials on air

Subscribe